- Home
- SVRN vs BFRG Comparison
SVRN vs BFRG Comparison
Compare SVRN & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVRN | BFRG |
|---|---|---|
| Founded | 2021 | 2017 |
| Country | Greece | United States |
| Employees | 87 | 17 |
| Industry | Marine Transportation | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 13.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SVRN | BFRG |
|---|---|---|
| Price | $8.40 | $0.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.3K | ★ 201.3K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $0.43 |
| 52 Week High | $15.07 | $2.04 |
Technical Indicators
Market Signals| Indicator | SVRN | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 52.02 |
| Support Level | $8.16 | $0.62 |
| Resistance Level | $8.99 | $0.71 |
| Average True Range (ATR) | 0.67 | 0.06 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 42.29 | 73.02 |
Price Performance
Historical ComparisonAbout SVRN OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.